SS
SBC

Sunbelt Securities’s SBC Medical Group SBC Stock Holding History

Sunbelt Securities’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8 Buy
2
+1
+100% +$4 ﹤0.01% 2931
2025
Q4 		$4 Buy
+1
New +$4 ﹤0.01% 2780

Other funds holding SBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sunbelt Securities's SBC Position: Q1 2026 in Review

Sunbelt Securities increased its SBC Medical Group (SBC) stake by 100% in Q1 2026, buying an estimated $4 and bringing the position to 2 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #2931.

Sunbelt Securities first reported a position in SBC in Q4 2025 and has held it in 2 quarters since. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Sunbelt Securities held 2 shares of SBC Medical Group worth $8 as of Q1 2026.
  • Sunbelt Securities bought 1 SBC Medical Group share in Q1 2026, an estimated $4.
  • SBC Medical Group made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2931 holding.
  • Sunbelt Securities first reported a position in SBC Medical Group in Q4 2025 and has held it in 2 quarters since.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.